Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 10/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.34 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6754237 | 0.85 | AR (0.49) | ARKIF11ALDH1A1 | |
| SCHEMBL6754193 | 0.85 | AR (0.49) | ARKIF11ALDH1A1 | |
| SCHEMBL6754239 | 0.85 | AR (0.49) | ARKIF11ALDH1A1 | |
| SCHEMBL13920389 | 0.82 | KIF11 (0.37) | KIF11ESR1ESR2TRPV1TRPV4 | |
| SCHEMBL11472931 | 0.80 | AR (0.42) | ARESR1ESR2ALOX15HSD17B10 | |
| SCHEMBL13933766 | 0.80 | AR (0.44) | ARKIF11ESR1ESR2TRPV1 | |
| SCHEMBL22297852 | 0.80 | AR (0.44) | ARKIF11ESR1ESR2TRPV1 | |
| SCHEMBL14822782 | 0.78 | MTNR1A (0.36) | ARKIF11ESR1ESR2TRPV1 | |
| SCHEMBL21243002 | 0.77 | AR (0.40) | ARESR1ESR2ALDH1A1 | |
| SCHEMBL4133012 | 0.77 | AR (0.40) | ARESR1ESR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7459564-B2 | Substituted biaryl compounds as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-12-02 | — | — | US | disclosed |